ORC Expert Advisory Services ORC International

  home    |    find an expert    |    request an expert    |    join our network    |    about us     expert login  
Expert Consulting and Expert Witness Services
  search tips 
Share this page:  Send to LinkedIn Send to Facebook Tweet This Email Print

 Expert  729289

Expert in Targeted Therapies for Human Tumours

Available for your Consulting and Expert Witness Needs

Education Work History Career AccomplishmentsPublicationsConsulting Services Expert Witness

Summary of Expertise:

Listed with other top experts in: 

Expert's group has been working from many years on new treatments for mesothelioma. These new treatments are called "translational therapies" because are directly translated from preclinical research applied to thoracic malignancies.

antitumor drug


asbestos human health effect




cancer biology


cancer immunotherapy


cancer research


cancer treatment






pleural tumor

Show Secondary and Basic Areas of Expertise

Year   Degree   Subject   Institution   Honors
1988   PhD   Oncology   Turin University  
1982   MD   Medicine   Genoa University   Magna cum Laude

Work History:
Years   Employer   Department   Title   Responsibilities

2014 to


(Undisclosed University)


Biomedical Research Center


Chair in Cancer Research


Teaching, Research, Clinical work

1999 to


(Undisclosed University)




Head of Dept


1999- to present: Head the Dept of General Medicine. Expert's University, Italian NHS, Vercelli, Joined with Oncology Dept Novara University (I) Scientific Director of the Lab of Clinical Oncology Local Health Authority Vercelli, Piedmont (I) General Medicine Dept with 25 acute beds, 20 beds of post acute beds 4 beds for day ward and 5 units (Internal Medicine, Respiratory Diseases, Medical Oncology, Gastro-enterology and Endocrinology) for the out- patients General duties: Clinical activity of internal medicine, medical oncology and respiratory medicine. Respiratory Endoscopic Procedures: diagnostic and interventional procedures Supervision and Resources management: Every year ca. 1500 patients are approximately discharged from the ward and 400-500 new out-patients come to the clinical units for clinical evaluation Supervisor and Responsible of the whole activity. Most of the activity for in-patients is spent with acute diseases or re-exacerbations of chronic or malignant disorders (Asthma, COPD, Ischemic Cardiac Diseases , neoplastic and non neoplastic terminally ill patients etc) Expert is also directly and fully responsible of a busy unit of medical oncology aimed at the diagnosis, staging, treatment (chemotherapy) and follow-up of the most common solid tumours. He also arranged the start-up and has been leading a unit of Day Service exclusively aimed at the diagnosis and staging of patients with suspected cancer (One stop service). Moreover over the last seven years he has been personally running a unit of thoracic oncology for diagnosis and treatment of thoracic malignancies and set up a tertiary national referral centre for innovative translational therapies for Thoracic Malignancies. Expert leads the outpatients clinic for respiratory diseases and the lab of Pulmonary Function. This lab is also in charge of the second level evaluation of symptomatic workers with exposure to occupational airborne contaminants Clinical Management of the patients is decided through daily ward rounds and clinical meetings chaired by the candidate. The out patients are mainly managed through Day Service and Day Ward Chairman of Italian Association for study and Therapy of Malignant Mesothelioma: G.I.Me. www.gime.unige.it; www.gime.it) and Chair of the Buzzi Foundation SAB Expert coordinates and is directly in charge of the financial support of a broad range of preclinical/translational activities (across Europe and US) aimed at arranging a multidisciplinary approach to thoracic malignancies with particular interest in asbestos related tumours. Care of several patients with this aggressive cancer and treats them either with “traditional” or “innovative “ therapies according to the stage of the diseases and the ethical committees permits (ca 50 pts/yr) (Translational Research Activity aimed at pre-clinical and clinical testing of new drugs and diagnosis in human cancers). Currently PI of Clinical and preclinical research focused on Chemotherapy for Lung Cancer and new translational approaches for Thoracic malignancies: • Phase II clinical Trial with Bortezomib for Mesothelioma (UK, NI, Republic of Ireland, Belgium, Holland) • Phase II Clinical Trial Imatinib/Gemcitabine for Meso (Italy) • Phase II clinical Trial with Trabectedine for first line treatment of sarcomatous mesotehlioma and for second line of mixed, epithelial mesothelioma • Phase II Clinical Trial with anti Abs to CTLA4 for second line treatment for Meso

Moreover am sub PI of the following  ICORG Phase III Adjuvant Breast Ca TC/Bevacizumab vs TC or TAC  ICORG Phase II Neo-Adjuvant Breast Ca TC/Trastuzumab vs TC/Lapatinib or TC/Trastuzumab/Lapatinib

Lead Physician of the Lung Cancer MDT meeting.

Career Accomplishments:

Past Member of the Piedmont Oncology Board for the study of MM. Past Consultant for the Italian Foreign Affairs Ministry for the U.S.A-Italy. scientific cooperation; Consultant of the National Toxicology Commission; Member of the Committee of the Advanced Biotechnology Center (CBA) of Genoa Chairman of the Scientific Committee Fondazione Buzzi for Pleural Mesothelioma; Member of the Science Advisory Board Mesothelioma Applied Research Foundation; Expert Leader of European Respiratory Society for Chemotherapy and Novel Therapies for Pleural Mesothelioma; Italian Director of the International Mesothelioma Interest Group, International Board; Chairman of the Italian Group for the study and Therapy of Malignant Mesothelioma; EU Consultant of the European Research Commission for “Treatment Trials for Rare cancers;” Member of the Editorial Board of the Journal Oncology Reviews; Member of the Editorial Borad of ISRN Oncology; Peer reviewer for Cancer Research, Clin Cancer Res, European Respiratory Journal, PNAS, J of Cellular and Molecular Medicine, Lung cancer, Thorax, J of Occupational Medicine and Toxicology, PLOS, PLOSone;

FM Association of the Italian Chest Physicians; FM European Respiratory Society; FM Italian Society of Respiratory Medicine; FM International Society of Translational Medicine.

Publications and Patents Summary

He has approximately 95 indexd publications on PubMed.

Consulting Services:
Click the green button above to contact Expert for a free initial screening call regarding your expert consulting needs.  Expert is available for consulting to corporate, legal and government clients.  Remember, your initial screening call to speak with Expert is free.

Expert Witness:
Expert Witness Experience Summary:
Hearing by Italian government for environmental human tumours.
Click the green button above to contact Expert for a free initial screening call regarding expert testimony, litigation consulting and support, forensic services, or any related expert witness services.  A few litigation needs include product liability, personal injury, economic loss, intellectual property (patent, trademark, trade secret, copyright), and insurance matters.  Remember, your initial screening call to speak with Expert is free.

Language Skills:
Foreign Language  

Additional Skills and Services:

He has taught several courses and delevered many conferences over the last several years.


Need the right expert?  We can help!

home       find an expert       request an expert       join our network       about us

Intota is now ORC Expert Advisory Services